In an age and gender-based US national retrospective analysis, overall 30-day readmission in multiple sclerosis (MS) was ∼10%, with higher readmission rates observed in older patients. The retrospective observational cohort study included patients hospitalized with primary discharge diagnosis of MS using 2013 Nationwide Readmission Database (NRD). Age (<40 vs >40 years) and gender-based analyses were performed using multivariable logistic regression adjusting co-variables to identify the patient/system-specific factors associated with 30-day readmission. Researchers found:
- 30-day readmission rate in MS was 10.2% in the cohort.
- Higher 30-day readmission was observed in patients aged >40 years due to burden of comorbidities.
- Readmission causes were MS exacerbations, sepsis, and respiratory complications.
- Readmission was associated with higher cost of care and longer length of stay compared to index admissions.
Patel S, SirDeshpande P, Desai R, et al. Thirty-day readmissions in multiple sclerosis: An age and gender-based US national retrospective analysis. [Published online ahead of print March 20, 2019]. Mult Scler Relat Disord. doi: 10.1016/j.msard.2019.03.012.